March 28, 2019

Case Study: Process for Production of Oncolytic Adenovirus

vaccinesThe promising results from clinical studies on the use of viral vectors to address important medical needs have spurred interest in developing scalable and cost-efficient manufacturing processes. Here, we present a case study from a biomanufacturer developing a process for adenovirus oncolytic adenovirus production. The case study describes a process from upstream cell culture to downstream purification, using scalable modern tools and technologies.

Tags: vaccines, bioprocess, oncolytic virus, adenovirus, viral vector production